Investor List:
Top Diagnostics Series B Investors (19)
Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Investors in Auburn (AL), Investors in Fremont (CA), Investors in Palo Alto (CA), Investors in Columbus (OH)
Investors in Boston (MA)
Investors in BioTech, Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices
Investors in Boston (MA)
Investors in AI, Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Diagnostics, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT
Investors in Cambridge (MA)
Investors in Boston / New England (Other Lists), Investors in Diagnostics, Investors in Diagnostics, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Investors in Boston (MA)
Investors in BioTech, Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Diagnostics, Investors in Diagnostics, Investors in Medical Devices, Investors in Medical Devices
Investors in Chattanooga (TN)
Investors in BioTech, Investors in Diagnostics, Investors in Digital Health, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Investors in SF Bay Area (CA)
Investors in BioTech, Investors in Diagnostics, Investors in Digital Health, Investors in Medical Devices, Investors in San Francisco Bay Area (Other Lists)
Investors in London
Investors in BioTech, Investors in Diagnostics, Investors in Health & Hospital Services, Investors in Health IT, Investors in London (Other Lists), Investors in Medical Devices, Investors in Pharmaceuticals
Get new data & insights delivered to your inbox